• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“微生物组”:新冠疫情时代的一个关键因素。

The "Microbiome": A Protagonist in COVID-19 Era.

作者信息

Merra Giuseppe, Capacci Annunziata, Cenname Giuseppe, Esposito Ernesto, Dri Maria, Di Renzo Laura, Marchetti Marco

机构信息

Section of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.

Department of Medical and Surgical Sciences, Agostino Gemelli General Hospital Foundation-IRCCS, 00168 Rome, Italy.

出版信息

Microorganisms. 2022 Jan 26;10(2):296. doi: 10.3390/microorganisms10020296.

DOI:10.3390/microorganisms10020296
PMID:35208751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8879283/
Abstract

Respiratory infections are among the main causes of hospitalization and mortality, particularly in elderly patients [...].

摘要

呼吸道感染是住院和死亡的主要原因之一,尤其是在老年患者中[...]。

相似文献

1
The "Microbiome": A Protagonist in COVID-19 Era.“微生物组”:新冠疫情时代的一个关键因素。
Microorganisms. 2022 Jan 26;10(2):296. doi: 10.3390/microorganisms10020296.
2
Analysis of Lung Microbiome in COVID-19 Patients during Time of Hospitalization.新冠病毒肺炎患者住院期间肺部微生物群分析
Pathogens. 2023 Jul 17;12(7):944. doi: 10.3390/pathogens12070944.
3
Impact of the COVID-19 pandemic on hospitalizations of children with neurologic impairment.COVID-19 大流行对伴有神经功能障碍儿童住院的影响。
J Hosp Med. 2023 Jan;18(1):33-42. doi: 10.1002/jhm.13021. Epub 2022 Dec 12.
4
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
5
Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19.COVID-19 感染早期儿童上呼吸道和肠道微生物组的逐渐恶化。
J Genet Genomics. 2021 Sep 20;48(9):803-814. doi: 10.1016/j.jgg.2021.05.004. Epub 2021 May 29.
6
SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与免疫微生物组相互作用:呼吸道病毒感染的经验教训
Int J Infect Dis. 2021 Apr;105:540-550. doi: 10.1016/j.ijid.2021.02.071. Epub 2021 Feb 18.
7
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.危重症 2019 冠状病毒病(COVID-19)患者口咽微生物组中严重的生态失调及特定嗜血杆菌和奈瑟菌特征标志。
Clin Infect Dis. 2022 Aug 24;75(1):e1063-e1071. doi: 10.1093/cid/ciab902.
8
Changes in respiratory infection trends during the COVID-19 pandemic in patients with haematologic malignancy.COVID-19 大流行期间血液恶性肿瘤患者呼吸道感染趋势的变化。
BMC Pulm Med. 2024 May 26;24(1):259. doi: 10.1186/s12890-024-03071-0.
9
Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.COVID-19 严重程度和呼吸道微生物组免疫反应特征。
mBio. 2021 Aug 31;12(4):e0177721. doi: 10.1128/mBio.01777-21. Epub 2021 Aug 17.
10
Inter-hospital Variation in COVID-19 Era Pediatric Hospitalizations by Age Group and Diagnosis.不同年龄段和诊断的 COVID-19 时代儿科住院的医院间差异。
Hosp Pediatr. 2023 Oct 1;13(10):e285-e291. doi: 10.1542/hpeds.2023-007287.

引用本文的文献

1
Feed the Eye to Heal the Eye.以眼养眼。
J Curr Ophthalmol. 2024 Mar 29;35(3):209-215. doi: 10.4103/joco.joco_94_23. eCollection 2023 Jul-Sep.
2
Effectiveness of Nutritional Supplements for Attenuating the Side Effects of SARS-CoV-2 Vaccines.营养补充剂对减轻 SARS-CoV-2 疫苗副作用的有效性。
Nutrients. 2023 Apr 7;15(8):1807. doi: 10.3390/nu15081807.

本文引用的文献

1
Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic.综述文章:2019冠状病毒病大流行期间的益生菌、益生元及饮食方法
Trends Food Sci Technol. 2021 Feb;108:187-196. doi: 10.1016/j.tifs.2020.12.009. Epub 2020 Dec 14.
2
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
3
Preventing COVID-19-induced pneumonia with anticytokine therapy.用抗细胞因子疗法预防新冠病毒感染所致肺炎
Lancet Rheumatol. 2020 May;2(5):e255-e256. doi: 10.1016/S2665-9913(20)30092-8. Epub 2020 Apr 6.
4
Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles.考虑微生物组和饮食对 SARS-CoV-2 感染的影响:纳米技术的作用。
ACS Nano. 2020 May 26;14(5):5179-5182. doi: 10.1021/acsnano.0c03402. Epub 2020 May 1.
5
Probiotics and COVID-19: one size does not fit all.益生菌与新冠病毒:并非一概而论。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):644-645. doi: 10.1016/S2468-1253(20)30122-9. Epub 2020 Apr 25.
6
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
7
A multidimensional approach to frailty in older people.老年人衰弱的多维方法。
Ageing Res Rev. 2020 Jul;60:101047. doi: 10.1016/j.arr.2020.101047. Epub 2020 Mar 21.
8
Evidence for Gastrointestinal Infection of SARS-CoV-2.新型冠状病毒2019(SARS-CoV-2)胃肠道感染的证据。
Gastroenterology. 2020 May;158(6):1831-1833.e3. doi: 10.1053/j.gastro.2020.02.055. Epub 2020 Mar 3.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
Management of frailty: opportunities, challenges, and future directions.虚弱管理:机遇、挑战与未来方向。
Lancet. 2019 Oct 12;394(10206):1376-1386. doi: 10.1016/S0140-6736(19)31785-4.